APR 11, 2018 10:30 AM PDT

How Can CellenONE Technology Help You Automate Cell Line Development?

C.E. CREDITS: P.A.C.E. CE | Florida CE
  • Vice President, Business Development, Scienion
      Barbara McIntosh, Vice President for Business Development at SCIENION US since 2016. For over 20 years, Barbara has been working in the diagnostic and life science marketplace on specific point of care applications like continuous glucose monitoring (CGM), lateral flow, multiplex arrays, and other microfluidic devices. She has been both an invited speaker at global conferences as well as a published author. She holds a BS degree in Biology and a MS in Management.
    • Marketing Manager, Scienion
        Originally from Spain, Alba holds a Master's Degree in Chemical Engineering from Strasbourg University and has been employed at SCIENION for two years now. She has been working closely with key accounts on the Mediterranean area, including diagnostic companies, medical centres and hospitals and research institutes in Spain, France, Italy and Portugal to introduce SCIENION dispensing technology and new cellenONE technology. Since recently, she is heading the Marketing Department.
      • Scientific and General Director, Cellenion
          Guilhem studied Chemistry at the IUT of Montpellier, after an industrial placement at Unilever in Liverpool, he decided to further his study in the United Kingdom. There he undertook a Masters in Applied Chemistry from Kingston University and then received a PhD in high throughput Chemical Biology under the supervision of Professor Mark Bradley at the University of Edinburgh. After graduating he worked for several start-up companies. At Smart Holograms, he worked on the development of biosensors for glucose monitoring. At Altrika, he was project manager and developed biomaterials for stem cell culture and bacterial enrichment. In 2013, he decided to return to France and started working as sales manager and business developer for a German company called SCIENION AG. As part of this position, he established a business plan to investigate novel markets and applications related to precision cell dispensing. This latest assignment led to the creation of Cellenion in 2016, and his appointment as Scientific and Managing director. Cellenion is based in Lyon and specializes in the fields of bioprinting and single-cell isolation.


        Historically single cell isolation techniques suffered from poor efficiency, low recovery and difficult automation, among other limitations. This presentation will highlight cellenONE, a piezo-acoustic and visual feedback technology to isolate and dispense single cells. Case studies have shown outstanding accuracy, high viability; both crucial parameters for cell line development.

        Show Resources
        Loading Comments...